MULTICENTRIC RETICULOHISTIOCYTOSIS (MRH): A CASE REPORT ON A RARE DESTRUCTIVE ARTHRITIS
DOI:
https://doi.org/10.55519/JAMC-02-9261Keywords:
Multicentric Reticulohistiocytosis, MRH, arthritis, inflammatory arthritisAbstract
Multicentric Reticulohistiocytosis is a rare disorder of unknown aetiology which affects skin and joints predominantly. There are no specific laboratory investigations for diagnosis. Diagnosis can be made clinically and on histopathological basis. There is no consensus on treatment. We report a case from Pakistan with classical presentation who did well on methotrexate and low dose steroids. Prompt diagnosis and early treatment may save from significant disability.References
Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Firestein & Kelley’s textbook of rheumatology. Elsevier Health Sciences: 2020; p.697–8.
Saba R, Kwatra SG, Upadhyay B, Mirrakhimov AE, Khan FN. Multicentric reticulohistiocytosis presenting with papulonodular skin lesions and arthritis mutilans. Case Rep Rheumatol 2013;2013:201563.
Sarkar S, Fung MA, Raychaudhuri SP. "Coral bead sign" in Multicentric Reticulohistiocytosis. Int J Dermatol 2020;59(6):e203–4.
El-Haddad B, Hammoud D, Shaver T, Shahouri S. Malignancy-associated multicentric reticulohistiocytosis. Rheumatol Int 2011;31(9):1235–8.
Kim S, Khatchaturian EM, Dehesa L. Multicentric reticulohistiocytosis: A case report with response to adalimumab. Clin Case Rep 2020;8(8):1560–3.
Sanchez-Alvarez C, Sandhu AS, Crowson CS, Wetter DA, McKenzie GA, Lehman JS, et al. Multicentric reticulohistiocytosis: the Mayo Clinic experience (1980–2017). Rheumatology 2019;59(8):1898–905.
Macía-Villa CC, Zea-Mendoza A. Multicentric reticulohistiocytosis: case report with response to infliximab and review of treatment options. Clin Rheumatol 2016;35(2):527–34.
Farokhi A, van Vugt RM, Hoekzema R, Nurmohamed MT. Multicentric reticulohistiocytosis: a case report. BMC Res Notes 2018;11(1):647.
Camargo K, Pinkston O, Abril A, Sluzevich JC. Xanthomatous Multicentric Reticulohistiocytosis: An Underrecognized Variant. J Clin Rheumatol 2018;24(5):285–7.
Sin CZ, Cheng YP, Tsai TF. Papular xanthoma with destructive arthritis (a variant of multicentric reticulohistiocytosis): Reports of two cases. Dermatol Sin 2019;37(3):174–5.
Toz B, Büyükbabani N, İnanç M. Multicentric reticulohistiocytosis: Rheumatology perspective. Best Pract Res Clin Rheumatol 2016;30(2):250–60.
Zou XJ, Qiao L, Li F, Chen H, Yang YJ, Xu D, et al. Clinical characteristics of multicentric reticulohistiocytosis and distinguished features from rheumatoid arthritis: a single-center experience in China. Orphanet J Rare Dis 2022;17(1):164.
Saito K, Fujii K, Awazu Y, Nakayamada S, Fujii Y, Ota T, et al. A case of systemic lupus erythematosus complicated with multicentric reticulohistiocytosis (MRH): successful treatment of MRH and lupus nephritis with cyclosporin A. Lupus 2001;10(2):129–32.
Cheng L-h, Chiang Y-YJDs. Multicentric reticulohistiocytosis in a Taiwanese woman with Sjögren syndrome. Dermato Sin 2016;34(1):42–5.
Chandwar K, Dogga P, Dixit J, Ekbote D, Kishor K, Kumar PJR. Flare of multicentric reticulohistiocytosis in pregnancy. Rheumatology (Oxford) 2022;61(6):e163–4.
Tang Z, Wang X, Xia Z, Wang Z, Zhao Y, Liu Y. Case Report: Multicentric Reticulohistiocytosis Associated With Posterior Mediastinal Adenosquamous Carcinoma, Antinuclear Antibody Positivity and Lupus Anticoagulant Positivity. Front Immunol 2021;12:749669.
Bonometti A, Berti E. Reticulohistiocytoses: a revision of the full spectrum. J Eur Acad Dermatol Venereol 2020;34(8):1684–94.
Eduardo J, Calonje TB, Lazar A, Billings S. McKee's Pathology of the Skin. 5th Edition ed, Elsevier; 2019. 1980; p.1507–8.
Tariq S, Hugenberg ST, Hirano-Ali SA, Tariq H. Multicentric reticulohistiocytosis (MRH): case report with review of literature between 1991 and 2014 with in depth analysis of various treatment regimens and outcomes. Springerplus 2016;5:180.
Additional Files
Published
Issue
Section
License
Copyright (c) 2023 Saira Bano, Tayyeba Khursheed, Mohammad Khalid Bosan, Sadia Khurshid
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
